New injection could cut costly anemia drug doses for kidney patients
NCT ID NCT07160452
Summary
This study is testing whether adding a supplement called levocarnitine to standard care can help reduce the amount of expensive anemia medication needed by people on kidney dialysis. It will involve 94 adults who have been on dialysis for at least six months and have anemia. Participants will be randomly assigned to receive either the supplement injections after dialysis or continue with their usual care for six months to compare results.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.